Search results for "vascular complications"

showing 10 items of 11 documents

Granulocyte cytosolic calcium in type 2 diabetes

2005

Diabetic vascular complicationsPolymorphonuclear leukocyte functionPolymorphonuclear leukocyte metabolism
researchProduct

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy

2020

Background Few data are available on the rate and characteristics of thromboembolic complications in hospitalized patients with COVID-19. Methods We studied consecutive symptomatic patients with laboratory-proven COVID-19 admitted to a university hospital in Milan, Italy (13.02.2020–10.04.2020). The primary outcome was any thromboembolic complication, including venous thromboembolism (VTE), ischemic stroke, and acute coronary syndrome (ACS)/myocardial infarction (MI). Secondary outcome was overt disseminated intravascular coagulation (DIC). Results We included 388 patients (median age 66 years, 68% men, 16% requiring intensive care [ICU]). Thromboprophylaxis was used in 100% of ICU patients…

MaleComorbidity030204 cardiovascular system & hematologyBrain Ischemia0302 clinical medicineHospitals UrbanPatient AdmissionRisk FactorsPulmonary angiographyAmbulatory CareThrombophiliaCardiovascular complicationsMyocardial infarctionHospital MortalityAged 80 and overHematologyMiddle AgedPulmonary embolismItaly030220 oncology & carcinogenesisAmbulatoryFemaleCoronavirus InfectionsVenous thromboembolismmedicine.medical_specialtyAcute coronary syndromeCritical CarePneumonia ViralArterial Occlusive DiseasesDisseminated intravascular coagulationThrombophiliaArticle03 medical and health sciencesInternal medicineIntensive caremedicineHumansAcute Coronary SyndromeMortalityHospitals TeachingPandemicsAgedRetrospective Studiesbusiness.industryCoronary ThrombosisAnticoagulantsCOVID-19Retrospective cohort studyLength of Staymedicine.diseaseSARS-CoV2businessPulmonary EmbolismThrombosis Research
researchProduct

2013 ESH/ESC Guidelines for the management of arterial hypertension

2013

Because of new evidence on several diagnostic and therapeutic aspects of hypertension, the present guidelines differ in many respects from the previous ones. Some of the most important differences are listed below: 1. Epidemiological data on hypertension and BP control in Europe. 2. Strengthening of the prognostic value of home blood pressure monitoring (HBPM) and of its role for diagnosis and management of hypertension, next to ambulatory blood pressure monitoring (ABPM). 3. Update of the prognostic significance of night-time BP, white-coat hypertension and masked hypertension. 4. Re-emphasis on integration of BP, cardiovascular (CV) risk factors, asymptomatic organ damage (OD) and clinica…

Maleblood pressure measurementPhysiologyEnfermedad cardiovascularWhite coat hypertensionLeft ventricular hypertrophyEpidemiologyfollow-upguidelinesblood pressureGeneral MedicineMiddle AgedEuropeOrgan damageRenal sympathetic denervationCardiologyFemaleCardiology and Cardiovascular MedicineRisk assessmentAdultcardiovascular risklifestylemedicine.medical_specialtyhypertensionAmbulatory blood pressureorgan damagecardiovascular complicationsCardiologíaPrehypertensionantihypertensive treatmentYoung AdultDevice therapyInternal medicineHipertensiónInternal MedicinemedicineHumansdevice therapyLife StyleAntihypertensive AgentsSistema cardiovascularAgedTask forcebusiness.industryta3121medicine.diseaseMasked HypertensionBlood pressureIntima-media thicknessbusinessJournal of Hypertension
researchProduct

Predictors of microvascular complications in type 1 diabetic patients at onset: The role of metabolic memory

2011

Background Several epidemiological studies showed a close association between metabolic control and microvascular complications in type 1 Diabetes Mellitus (T1DM). The aim of our longitudinal observational study was to evaluate the predictive role of the main clinical and biochemical parameters in determining microvascular complications. Methods 376 T1DM patients, hospitalized in our division from 1991 to 2005 (mean follow-up = 10.93 ± 4.26 years) were studied. Stepwise Cox regression analysis was used to identify the influence of residual ß-cell function, ß-cell autoimmunity, HbA1c levels and other clinical and laboratory parameters in the development of microalbuminuria and retinopathy. R…

Malemedicine.medical_specialtyAdolescentendocrine system diseasesSettore MED/13 - EndocrinologiaNephropathyYoung AdultPredictive Value of TestsInsulin-Secreting CellsInternal medicineDiabetes mellitusInternal MedicinemedicineAlbuminuriaHumansDiabetic NephropathiesLongitudinal StudiesAge of OnsetChildAutoantibodiesProportional Hazards ModelsGlycated HemoglobinInpatientsType 1 diabetesDiabetic Retinopathybusiness.industryMicrocirculationMicroangiopathyType 1 diabetes microvascular Complicationsnutritional and metabolic diseasesmedicine.diseaseSurgeryDiabetes Mellitus Type 1Metabolic control analysisPredictive value of testsFemaleMicroalbuminuriaAge of onsetbusinessDiabetic AngiopathiesFollow-Up StudiesEuropean Journal of Internal Medicine
researchProduct

Trocar-related abdominal wall bleeding in 200 patients after laparoscopic cholecistectomy: Personal experience

2006

AIM: To determine the complications and incidence of the first and second access-related vascular injuries induced by videolaparoscopic cholecistectomy. METHODS: We retrospectively reviewed vascular injuries in 200 consecutive patients who underwent videolaparoscopic cholecistectomy from 2003 to 2005. One hundred and one patients with placement of radial expanding trocars were assigned into group A and 99 patients with placement of pyramidal tipped trocars into group B. All the patients were submitted to open access according to Hasson for the first trocar. RESULTS: Bleeding did not occur at the intraoperative cannula-site in group A. However, it occurred at the intraoperative cannula-site …

Malemedicine.medical_specialtyTrocarVideolaparoscopyBlood Loss SurgicalAbdominal cavityAbdominal wallVideolaparoscopy; Minor vascular complications; Trocars; PreventionHumansMedicineMajor complicationLaparoscopic cholecystectomyMinor vascular complicationRetrospective Studiesbusiness.industryPreventionAbdominal WallSignificant differenceGastroenterologyRetrospective cohort studyGeneral MedicineMiddle AgedSurgerymedicine.anatomical_structureCholecystectomy LaparoscopicBlood VesselsDirect visionFemalebusinessRapid CommunicationWorld Journal of Gastroenterology
researchProduct

Cardiovascular complications in COVID-19:A systematic review and meta-analysis

2020

Microbiology (medical)2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralBioinformaticsBetacoronavirusPandemicMedicineHumansCardiovascular complicationsPandemicsinfektiotauditRetrospective Studiesbiologybusiness.industrySARS-CoV-2COVID-19Covid19komplikaatiotbiology.organism_classificationCardiovascular diseaseInfectious Diseases/dk/atira/pure/core/keywords/uob_covid19Cardiovascular DiseasesMeta-analysissydän- ja verisuonitauditbusinessCoronavirus InfectionsBetacoronavirus
researchProduct

Vascular complications on arterial puncture site after coronaric and peripheral angiography

2011

Il cateterismo cardiaco, l'angiografia coronarica e periferica e le procedure interventistiche sono tecniche contrastografiche che prevedono la visualizzazione radiografica dei vasi coronarici e periferici dopo l'iniezione selettiva di mezzo di contrasto radiopaco. Si tratta di tecniche relativamente sicure, anche se esiste un certo rischio di morbilità e mortalità. Nel nostro studio abbiamo valutato le varie complicanze mettendole in relazione con fattori demografici e clinici, terapie, caratteristiche della puntura e della procedura.

Settore MED/22 - Chirurgia Vascolarevascular complications arteriovenous fistula hematoma retroperitoneal hemorrhage pseudoaneurysm thrombosis coronaric and peripheral angiography
researchProduct

Femoral Versus Radial Artery Access for CTO PCIs: Is This the Final Round?

2022

Historically, cardiac catheterization has been performed via transfemoral access (TFA). Although TFA remains necessary in multiple diagnostic and interventional settings, this technique has been associated with vascular access site complication rates ranging from 2% to 6%, prolonged hospital stay, and more deaths compared with radial artery access. Furthermore, safe utilization of the femoral artery can be compromised by abdominal obesity, atherosclerosis at the puncture site, and antithrombotic therapy, all which increase the bleeding risk.1 In the last decade, transradial artery access (TRA) emerged as the recommended approach for percutaneous coronary interventions (PCI), particularly in…

complex PCICTO PCIvascular complications.transradial CTO PCI
researchProduct

Iatrogenic lumbar artery pseudoaneurysm after lumbar transpedicular fixation: Case report

2019

Only a few cases of iatrogenic lumbar injury have been reported in the literature. A 58-year-old male with severe back pain was admitted to our department. The patient was qualified for the transpedicular stabilization with interbody fixation at L4/L5 and L5/S1 levels. On the first day after surgery, the patient was mobile and reported significant pain relief. He was discharged the same day. After 2 weeks, the patient returned with severe right lower abdominal pain and radicular pain in his right leg. He was administered to the Neurology Department where the presence of a lumbar muscle hematoma and lumbar artery pseudoaneurysm were discovered. He was transferred to the Vascular Surgery Depa…

lcsh:R5-920medicine.medical_specialtybusiness.industryiatrogenic pseudoaneurysmVascular complicationsCase Reportposterior lumbar interbody fusion complicationGeneral Medicinemedicine.diseaseSurgerytranspedicular fixation03 medical and health sciencesPseudoaneurysm0302 clinical medicineLumbarmedicine.arterymedicineSevere back pain030212 general & internal medicinelcsh:Medicine (General)businessTranspedicular fixationendovasular embolisation030217 neurology & neurosurgeryLumbar arteriesSAGE Open Medical Case Reports
researchProduct

Covid-19 and Congenital Heart Disease: results from a nationwide survey

2020

Background. The pandemic of Novel Coronavirus Disease 2019 (COVID-19) is challenging, given the large number of hospitalized patients. Cardiovascular co-morbidities are linked to a higher mortality risk. Thus, patients with Congenital Heart Disease (CHD) might represent a high-risk population. Nevertheless, no data about them are available, yet. Hence, we conducted a nationwide survey to assess clinical characteristics and outcomes in patients with congenital heart disease affected by COVID-19. Methods and Results. This is a multi-centre, observational, nationwide survey, involving high-volume Italian CHD centres. COVID-19 diagnosis was defined as either &ldquo

medicine.medical_specialtyHeart diseasePopulationcardiovascular complicationslcsh:Medicine030204 cardiovascular system & hematologyChest painArticle03 medical and health sciences0302 clinical medicineDiabetes mellitusInternal medicinecongenital heart disease COVID-19 cardiovascular complicationsmedicinePalpitations030212 general & internal medicineeducationStrokecardiovascular complicationeducation.field_of_studybusiness.industrylcsh:Rcongenital heart disease; COVID-19; cardiovascular complicationsCOVID-19General Medicinemedicine.diseasecongenital heart diseaseHeart failureCohortmedicine.symptombusiness
researchProduct